scholarly article | Q13442814 |
P50 | author | Michael W Kattan | Q60653077 |
Jan Verbeek | Q51611013 | ||
Ewout W. Steyerberg | Q37828851 | ||
P2093 | author name string | Monique J Roobol | |
Chris Parker | |||
Daan Nieboer | |||
P2860 | cites work | MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. | Q52649258 |
Estimation in a competing risks proportional hazards model under length-biased sampling with censoring. | Q53115553 | ||
Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators | Q62673865 | ||
Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up | Q63965969 | ||
Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects | Q64120111 | ||
The impact of co-morbidity on life expectancy among men with localized prostate cancer | Q71122151 | ||
The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models | Q92058018 | ||
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | Q38939206 | ||
The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment | Q39233902 | ||
Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study | Q39738179 | ||
Assessing individual risk for prostate cancer | Q39809092 | ||
A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer. | Q39899527 | ||
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer | Q40125644 | ||
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. | Q45112412 | ||
Implications of the new AUA guidelines on prostate cancer detection in the U.S. | Q46619813 | ||
Eighteen-year follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality | Q47288274 | ||
Next-generation prostate cancer risk calculator for primary care physicians | Q47704685 | ||
Screening for prostate cancer | Q24201690 | ||
Overdiagnosis and overtreatment of prostate cancer | Q26859596 | ||
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer | Q28005473 | ||
Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer | Q33672510 | ||
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. | Q34041688 | ||
Impact of comorbidity on survival among men with localized prostate cancer | Q34879348 | ||
The Global Burden of Cancer 2013 | Q35847426 | ||
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. | Q35875135 | ||
Successful external validation of a model to predict other cause mortality in localized prostate cancer | Q35918818 | ||
20-year outcomes following conservative management of clinically localized prostate cancer | Q36115855 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | decision making | Q1331926 |
shared decision-making | Q7489544 | ||
P304 | page(s) | 19 | |
P577 | publication date | 2019-04-22 | |
P1433 | published in | Journal of personalized medicine | Q27724740 |
P1476 | title | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy | |
P478 | volume | 9 |
Search more.